News« Back to News
April 21, 2016 – New this year, the 2016 USP <800> Compliance Study registration is now available online and will remain open through June 30th this summer. With the landscape of hazardous drug compounding changing quickly, now is the time to make sure you have identified your operational updates, given the recently published guidelines. The study will allow you to conduct a comprehensive Gap Analysis so that you understand your level of compliance with the USP Chapter <800> Standards. Led by Eric Kastango, Rph, MBA, FASHP, and sterile compounding expert and Study Co-Director, Kate Douglass, MS, RN, CRNI.
The information obtained from this year’s Study will be very valuable to the compounding pharmacy industry. These results assist in benchmarking industry progress and identifying where additional resources and focus are required to continue to improve practices and safety. The results of this Study will be published this fall in Pharmacy Purchasing & Products Magazine.
The 2016 USP <800> Compliance Study uses a sophisticated, web-based Gap Analysis Tool that Douglass and Kastango developed and have been using for the last several years. This tool is being made available at no charge to all study participants. It should be noted that ALL INDIVIDUAL FACILITY RESULTS ARE CONFIDENTIAL – ONLY AGGREGATE DATA WILL BE USED IN THE STUDY REPORT.
In return for your participation, you will receive a highly detailed Action Plan that is automatically generated based on your responses. This Action Plan provides documentation that can be used to enhance your sterile compounding practices. The survey takes approximately 60-90 minutes to complete but does not have to be completed in one sitting. The Study Team has also provided a PDF document of all the questions to facilitate offline data collection for those who might find this useful. This will be available for download after you have registered and completed the first two informational sections of the survey.
Please register for the Study today: www.800gaptool.com - Use Survey Code F800A
Your participation will help the Study Team to learn more about the successes and challenges relative to USP <800> compliance. With that insight, it becomes easier to target additional strategies to promote best-practice sterile compounding. If you have any questions, please contact the Study Team at firstname.lastname@example.org.